NEW YORK (GenomeWeb News) – Amarantus BioScience today announced it has acquired all the intellectual property assets from Power3 Medical Products for $40,000.
Based in The Woodlands, Texas, Power3 filed for Chapter 7 bankruptcy earlier this year.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Science this week: measles virus nucleocapsid structure, and more.
African and US health officials work to establish an Africa-wide Centres for Disease Control and Prevention.
Nature has retracted a 2002 epigenetics paper for image manipulation.
The World Health Organization calls for the public release of clinical trial results within a year of the completion of data collection.
This online seminar will review case studies demonstrating the clinical utility of CTCs and cfDNA to define and characterize a variety of dynamic genomic changes throughout the course of cancer detection and treatment.